In contrast to other tumor types, MHC class I expression is associated with a poor prognosis in some MBs [9], possibly because of ERK activation by incomplete so-called conformer MHC class I molecule expression, deficient of beta-2-microglobulin and/or peptide expression [32]. The gene discussed is B2M; the disease is Mobius syndrome.